1. 'Why is survival with triple negative breast cancer so low? insights and talking points from preclinical and clinical research'. (2nd December 2022) Authors: Passalacqua, Maria Ilenia; Rizzo, Graziella; Santarpia, Mariacarmela; Curigliano, Giuseppe Journal: Expert opinion on investigational drugs Issue: Volume 31:Number 12(2022) Page Start: 1291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders. (April 2013) Authors: Mestre, Tiago A; Zurowski, Mateusz; Fox, Susan H Journal: Expert opinion on investigational drugs Issue: Volume 22:Number 4(2013:Apr.) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A case study of foliglurax, the first clinical mGluR4 PAM for symptomatic treatment of Parkinson's disease: translational gaps or a failing industry innovation model?. (1st December 2020) Authors: Doller, Dario; Bespalov, Anton; Miller, Rob; Pietraszek, Malgorzata; Kalinichev, Mikhail Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 12(2020) Page Start: 1323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A foreword on biliary tract cancers: emerging treatments, drug targets, and fundamental knowledge gaps. (3rd April 2021) Authors: Rizzo, Alessandro; Brandi, Giovanni Journal: Expert opinion on investigational drugs Issue: Volume 30:Number 4(2021) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations. (3rd August 2019) Authors: Babiker, Hani M; Davis, Lisa; Larson, Kristian; Placencia, Crystal; Swensen, Connor; Tenneti, Pavan; Lim, Melissa; Cañamar, Ruth; Curtis, Jacqueline; Castillo, Erica; Mancuso, James; Rensvold, Diane; Martinez, Sarah; Macias, Lora; Recio-Boiles, Alejandro; Chandana, Sreenivasa R; Mahadevan, Daruka Journal: Expert opinion on investigational drugs Issue: Volume 28:Number 8(2019) Page Start: 675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A new dawn for the use of thiazolidinediones in cancer therapy. (April 2014) Authors: Joshi, Hardik; Pal, Tanushree; Ramaa, CS Journal: Expert opinion on investigational drugs Issue: Volume 23:Number 4(2014:Apr.) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A perspective on RNA interference-based therapeutics for metabolic liver diseases. (4th March 2021) Authors: Alkhouri, Naim; Gawrieh, Samer Journal: Expert opinion on investigational drugs Issue: Volume 30:Number 3(2021) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer. (3rd July 2022) Authors: Cho, Byoung Chul; Goldberg, Sarah B; Kim, Dong-Wan; Socinski, Mark A; Burns, Timothy F; Lwin, Zarnie; Pathan, Nuzhat; Ma, Wei Dong; Masters, Joanna C; Cossons, Nandini; Wilner, Keith; Nishio, Makoto; Husain, Hatim Journal: Expert opinion on investigational drugs Issue: Volume 31:Number 7(2022) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A Phase I, Randomized, Double-Blind, Single-Dose, Parallel-Group Study to compare Pharmacokinetic Similarity, Safety, and Immunogenicity Between BAT2506 and Golimumab in Healthy Chinese Male Subjects. (2nd January 2021) Authors: Wu, Min; Sun, Jixuan; Wu, Dandan; Xu, Jia; Wei, Jin; Wang, Zhaohe; Yu, Jinchen; Li, Shengfeng; Zhang, Hong; Ding, Yanhua Journal: Expert opinion on investigational drugs Issue: Volume 30:Number 1(2021) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adults. (2nd July 2020) Authors: Wang, Jiaxue; Niu, Suping; Dong, Wenliang; Wei, Li; Ou, Lun; Zhang, Tan; Zhang, Liangbi; Nie, Xiaoyan; Wang, Qian; Shen, Tiantian; Wang, Qi; Xia, Lin; Liu, Gang; Jin, Jiting; Zheng, Qingshan; Song, Haifeng; Fang, Yi Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 7(2020) Page Start: 755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗